RONALD DAVIS to Oncolytic Viruses
This is a "connection" page, showing publications RONALD DAVIS has written about Oncolytic Viruses.
Connection Strength
0.031
-
An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results. Urol Oncol. 2018 10; 36(10):440-447.
Score: 0.031